Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Lisinopril Market’s Growth Rate Evolve Over the Forecast Period to 2034?

In recent times, the lisinopril market has seen robust growth. The market is set to rise from $1.76 billion in 2024 to $1.88 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.7%. The significant expansion during the historical period is due to factors such as enhanced accessibility, changes in lifestyles, more prevalent screening programs, improved access to generic lisinopril, and greater patient compliance.

It is projected that the lisinopril market will experience substantial growth in the coming years, expanding to a size of $2.4 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth during the predicted period include increased occurrence of high blood pressure and heart disorders, availability of generic versions providing cost efficiency, a rise in awareness and early disease detection, increased need for viable treatments, and an aging demographic. Key trends foreseen during the forecast period comprise breakthroughs in drug delivery, the necessity for improved patient-focused drug delivery methods, a shift towards cost-effective resolutions, an increased demand for treatment methods for heart failure, and a greater need for treatments for diabetes-related kidney disease.

How Are the key drivers Contributing to the Expansion of the Lisinopril Market?

The lisinopril market’s expansion can be anticipated due to the increasing instances of cardiovascular diseases. These diseases, which include a variety of disorders impacting the heart and blood vessels, have been expanding due to various reasons like growth of population, aging, risk factors, and the non-application of proven prevention and treatment methods. The important role of lisinopril is to regulate cardiovascular diseases by primarily lowering blood pressure and reducing the strain on the heart and kidneys. It achieves this by preventing the production of angiotensin II, causing the dilation of blood vessels, minimising blood volume, and safeguarding organs from damage. The Singapore Heart Foundation (SHF), a non-profit organization based in Singapore, reported an instance in May 2024 when ischemic heart diseases resulted in 5,302 deaths, a marginal increase from 5,290 deaths in 2022. Thus, the escalating prevalence of cardiovascular diseases is stimulating the growth of the lisinopril market.

Lisinopril Market Driver: Escalating Hypertension Cases Boosts The Lisinopril Market Growth

Request Your Free Lisinopril Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp

Who Are the Influential Players Reshaping the Lisinopril Market Landscape?

Major companies operating in the lisinopril market are:

• Merck & Co. Inc._x000D_

• Pfizer Inc._x000D_

• AbbVie Inc._x000D_

• AstraZeneca Plc_x000D_

• Vitaris Inc._x000D_

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

What Are the Main Segments of the Lisinopril Market, and How Are They Evolving?

The lisinopril market covered in this report is segmented –

1) By Brand: Zestoretic, Prinivil, Zestril, Other Brands

2) By Disease: Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Other Diseases

3) By Dosage: Tablet, Liquid, Other Dosages

4) By Population Type: Children, Adults

5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Zestoretic: Different Dosage Forms, Generic Versions Of Zestoretic

2) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil

3) By Zestril: Different Dosage Forms, Generic Versions Of Zestril

4) By Other Brands: International Brand Variants, Combination Drug Formulations

Which Geographic Locations Are Critical to the Growth of the Lisinopril Market?

North America was the largest region in the lisinopril market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Aspects of the Lisinopril Market Landscape?

Lisinopril is a medication classified as an angiotensin-converting enzyme (ACE) inhibitor. It functions by reducing specific chemicals that constrict blood vessels, promoting smoother blood flow and enhancing the heart’s ability to pump blood effectively. Lisinopril is prescribed to adults for the treatment of congestive heart failure and to increase survival rates following a heart attack.

Browse Through More Similar Reports By The Business Research Company:

Pre-Collision Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pre-collision-technology-global-market-report

Automotive Collision Repair Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-collision-repair-global-market-report

Anti-Collision Sensor Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-collision-sensor-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: